Please ensure Javascript is enabled for purposes of website accessibility

Why Shares of Rite Aid Surged 18% Today

By Jon Quast - Apr 20, 2020 at 3:57PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company can now provide testing for 4,800 people per day.

What happened

As of 3:35 p.m. on Monday, shares of Rite Aid (RAD -8.40%) had traded up as much as 17.6%. While investors have been concerned with the company's long-term prospects for much of the last year, they cheered the news that Rite Aid is expanding the availability of its COVID-19 testing to more sites. 

A full 24 Rite Aid locations now offer testing across eight states, in what the company calls "key hot spots."

A person shops in a pharmacy.

Image source: Getty Images.

So what

One of the keys to reopening the U.S. economy is widespread coronavirus testing. Washington, D.C., has sought to partner with the private sector, and Rite Aid is part of the solution. People who meet certain CDC guidelines can be tested for free at Rite Aid's drive-up testing locations. Participants must remain in their vehicles for the testing process.

Each testing location will be available from 9 a.m. to 5 p.m. and will accommodate up to 200 tests per day. This brings current capability to 4,800 tests daily. This is in line with the 5,000 daily tests Rite Aid previously pledged to the White House Coronavirus Task Force.

Now what

Laboratories conducting COVID-19 diagnostic tests are being reimbursed $100 per administered test. Rite Aid is partnered with BioReference Laboratories, a subsidiary of Opko Health (OPK 2.27%), which also popped with today's news. While Rite Aid investors are clearly enthusiastic, it's unclear what the compensation will be for providing the testing sites.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Rite Aid Corporation Stock Quote
Rite Aid Corporation
RAD
$7.96 (-8.40%) $0.73
OPKO Health, Inc. Stock Quote
OPKO Health, Inc.
OPK
$2.70 (2.27%) $0.06

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.